Neurogene Inc. (NASDAQ: NGNE) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT NEUROGENE INC.

Neurogene Inc. (NASDAQ: NGNE)
Listen to this Section


$21.94
+3.8600 ( +21.39% ) 414.5K

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Market Data


Open $21.94
Previous Close $18.08
Volume 414.5K
Market Cap $262.04M
Day Range $16.76 - $22.30
52 Week Range $14.42 - $74.49
Shares Outstanding 14.85M
Change % +21.39%
Net Change ▲ 3.8600
Insider Ownership 0.01%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2023
Country Canada

Insider Ownership Transactions

Total Amount Purchased: -240,683.00

Date Type Amount Purchased Purchaser
2024-11-27 Buy 20748.00 Samsara BioCapital GP, LLC
2024-11-25 Buy 47500.00 McMinn Rachel
2024-11-25 Buy 24000.00 Cvijic Christine Mikail
2024-06-17 Sale -7700.00 BAFFI ROBERT
2024-06-17 Sale -7700.00 Woods Robert Keith
2024-06-17 Sale -7700.00 PALEKAR ROHAN
2024-06-17 Sale -7700.00 Freedland Cory S.
2024-06-17 Sale -7700.00 Noonberg Sarah B.
2024-03-14 Sale -31903.00 Cvijic Christine Mikail
2024-03-14 Sale -93282.00 McMinn Rachel

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Nov 25, 2024
4 Insider transactions 1 Nov 25, 2024
8-k 8K-related 13 Nov 21, 2024
10-q Quarterly Reports 80 Nov 18, 2024
8-k 8K-related 15 Nov 18, 2024
8-k 8K-related 15 Nov 18, 2024
sc Insider transactions 1 Nov 14, 2024
nt Quarterly Reports 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024

Latest News


× Before browsing our site, please accept our cookies policy